Nanocrine
Frederick, US · 2 known investors
Nanocrine develops nanoplasmonic biosensor chips that let cell biology researchers image protein secretions from living cells in real time, without labels, using standard live-cell microscopes. Its single-use biochips apply surface plasmon resonance sensing to map extracellular secretions spatially, functioning like a real-time, microscope-based ELISA.
Founders & leadership
Investors · 2
Competitors · 1
by search overlapCompanies competing with Nanocrine for the same Google search keywords, organic and paid, via search-intersection analysis.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2020 | $248.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- What does Nanocrine do?
- Nanocrine develops nanoplasmonic biosensor chips that let cell biology researchers image protein secretions from living cells in real time, without labels, using standard live-cell microscopes. Its single-use biochips apply surface plasmon resonance sensing to map extracellular secretions spatially, functioning like a real-time, microscope-based ELISA.
- Who founded Nanocrine?
- Nanocrine was founded by Steve Turner, Jim Bailey.
- Who are Nanocrine's investors?
- Nanocrine's investors include Maryland TEDCO, TEDCO.
- Where is Nanocrine headquartered?
- Nanocrine is headquartered in Frederick, US.